Leica BioSystems Aperio Eslide Manager 12.3.2.5030 memo cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.0 | $0-$5k | 0.00 |
Summary
A vulnerability classified as problematic has been found in Leica BioSystems Aperio Eslide Manager 12.3.2.5030. Affected by this vulnerability is an unknown functionality. Performing a manipulation of the argument memo results in cross site scripting. This vulnerability is cataloged as CVE-2025-1888. It is possible to initiate the attack remotely. There is no exploit available.
Details
A vulnerability, which was classified as problematic, was found in Leica BioSystems Aperio Eslide Manager 12.3.2.5030. This affects some unknown processing. The manipulation of the argument memo with an unknown input leads to a cross site scripting vulnerability. CWE is classifying the issue as CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. This is going to have an impact on integrity. The summary by CVE is:
The Leica Web Viewer within the Aperio Eslide Manager Application is vulnerable to reflected cross-site scripting (XSS). An authenticated user can access the slides within a project and injecting malicious JavaScript into the "memo" field. The memo field has a hover over action that will display a Microsoft Tool Tip which a user can use to quickly view the memo associated with the slide and execute the JavaScript.
It is possible to read the advisory at blog.blacklanternsecurity.com. This vulnerability is uniquely identified as CVE-2025-1888 since 03/03/2025. The exploitability is told to be easy. It is possible to initiate the attack remotely. It demands that the victim is doing some kind of user interaction. Technical details of the vulnerability are known, but there is no available exploit. The attack technique deployed by this issue is T1059.007 according to MITRE ATT&CK.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
Product
Vendor
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.0VulDB Meta Temp Score: 4.0
VulDB Base Score: 3.5
VulDB Temp Score: 3.5
VulDB Vector: 🔍
VulDB Reliability: 🔍
CNA Base Score: 4.6
CNA Vector (BLSOPS): 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
03/03/2025 🔍03/14/2025 🔍
03/14/2025 🔍
03/14/2025 🔍
Sources
Advisory: blog.blacklanternsecurity.comStatus: Not defined
CVE: CVE-2025-1888 (🔍)
GCVE (CVE): GCVE-0-2025-1888
GCVE (VulDB): GCVE-100-299739
Entry
Created: 03/14/2025 17:59Changes: 03/14/2025 17:59 (62)
Complete: 🔍
Cache ID: 216::103
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.